Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
about
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewRole of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS studyDrugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network projectOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseThe epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivoMolecular targets of dietary polyphenols with anti-inflammatory propertiesPomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator propertiesFibrates, glitazones, and peroxisome proliferator-activated receptorsInterplay between oxidant species and energy metabolismIsoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic DiseaseAtheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDLPPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosisEffect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats.PPARalpha: energy combustion, hypolipidemia, inflammation and cancerImpaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertensionNitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligandA potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activityPPARα in Obesity: Sex Difference and Estrogen Involvement.Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatmentPeroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts.Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression.Antioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARgamma gene.An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats.Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterinAtherogenic ω-6 Lipids Modulate PPAR- EGR-1 Crosstalk in Vascular Cells.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.Unbuckling lipodystrophy from insulin resistance and hypertension.Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.Peroxisome proliferator-activated receptors and cardiovascular remodeling.Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.Reactive oxygen species signaling facilitates FOXO-3a/FBXO-dependent vascular BK channel β1 subunit degradation in diabetic mice.
P2860
Q24561401-9CF6B78C-A3FC-4219-BB36-BE4841183916Q24564203-16101536-81B1-45CB-A99A-6F1F838FC892Q24813954-B9AD9B45-6BF8-4BFD-A458-09017D8F06B3Q26749192-D679DDDD-FFF3-4ED0-8664-BBB8BCC16BBBQ26825517-E779677F-E3F1-419B-8F7F-9C2A045B94E1Q27339662-48D26141-C48C-47CB-B8F5-706C28896B51Q28192995-A6FE8B2B-BFB6-4A84-8671-332B52E247B9Q28261771-676F7195-DEFA-4CF1-8D5D-23389EC65C4BQ28279732-8E073AF0-7F9D-472B-8347-EFA83716A84DQ28383905-3D60EE22-22D4-47C9-8671-1D8EAE871872Q28387066-B278B19F-9153-44EF-8C80-078690E12A26Q28538861-9C9B916E-3072-4284-8D22-006311C19AE9Q28574163-E4B6F3A2-0FAD-4993-B5F7-E811557F0106Q30248650-7527184E-2931-416C-8A9A-31CCAC4893F5Q30476274-6300DB72-8434-4197-A78E-ABBAE687C2F2Q30482025-94B6259C-7C9E-45D0-94DE-339B0D79AE2CQ33593476-474B39A7-2447-4804-BF59-1A0DD9B96863Q33673698-BA6FDD00-EBE8-4DB7-A26D-1B667A55C6B9Q33805104-D56A0A37-D5BE-44EF-BC22-CA5D365EAA9AQ33810041-A46ABD34-2079-46DF-879B-7F3354D896A3Q33849597-6D12A000-8366-4452-B6AC-8FD68C8568E7Q34000354-21FCB5CD-3C37-48AE-90DE-921405AD2EB5Q34143769-8A8C0171-15F1-4752-A926-16886745C7CBQ34254138-07DF3BD2-E723-4A26-9F48-7C3C77DC632CQ34365179-224EDCEC-A013-41F1-9025-92447069F637Q34573108-AC38F6B3-9969-44FC-BDD6-D08848E9FA85Q34584762-D13853E8-A7CD-4F47-BBED-BA6EF501A2AFQ34589929-A3AC7647-6DC1-444B-A3A7-7DAD54BC6DDFQ34795810-10E74022-5712-4625-BF4B-28CEA57EE20FQ35040072-04C53D91-02B9-413D-8655-50D2C913E416Q35126265-AAD92C76-1A3D-4888-9106-281D3DBCCBC4Q35495395-305A0AF1-8F9B-4C70-B710-333570EB66CDQ35636191-CD096DF7-F226-4DD7-BDFF-4E1839A8DFE7Q35670922-3353AD27-D5C5-47AE-8327-A70523AA01B1Q35708138-2D881DBD-6C5D-4307-8228-DDF1B8A1EEE4Q35835637-94353E73-75FD-4E7E-91A8-02429DA27456Q35865401-6A7068D8-CD9E-480B-81D8-7D903C7B8F8DQ35890826-C6F46B0E-BD27-47C7-9520-F3702A318A25Q36038820-5DF898BE-623F-40FE-9DF5-4A82B85ED873Q36047479-921C7A2C-993E-43AB-8F2A-72F7FB298080
P2860
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Peroxisome proliferator-activa ...... expression in vascular cells.
@ast
Peroxisome proliferator-activa ...... expression in vascular cells.
@en
type
label
Peroxisome proliferator-activa ...... expression in vascular cells.
@ast
Peroxisome proliferator-activa ...... expression in vascular cells.
@en
prefLabel
Peroxisome proliferator-activa ...... expression in vascular cells.
@ast
Peroxisome proliferator-activa ...... expression in vascular cells.
@en
P1433
P1476
Peroxisome proliferator-activa ...... expression in vascular cells.
@en
P2093
Hélène Duez
Nikolaus Marx
P304
P356
10.1161/01.RES.0000127122.22685.0A
P577
2004-05-01T00:00:00Z